Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
Common Shares Outstanding
Bristol-Myers Squibb Co
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Shares Outstanding
$2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Johnson & Johnson
NYSE:JNJ
|
Common Shares Outstanding
$2.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
Pfizer Inc
NYSE:PFE
|
Common Shares Outstanding
$5.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
Merck & Co Inc
NYSE:MRK
|
Common Shares Outstanding
$2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
Zoetis Inc
NYSE:ZTS
|
Common Shares Outstanding
$456.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Shares Outstanding
$950.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Bristol-Myers Squibb Co's Common Shares Outstanding?
Common Shares Outstanding
2B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Common Shares Outstanding amounts to 2B USD.
What is Bristol-Myers Squibb Co's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
2%
Over the last year, the Common Shares Outstanding growth was -3%. The average annual Common Shares Outstanding growth rates for Bristol-Myers Squibb Co have been -3% over the past three years , 4% over the past five years , and 2% over the past ten years .